SIMG
MYGN icon

Stephens Investment Management Group’s Myriad Genetics MYGN Stock Holding History

Stephens Investment Management Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-498,546
Closed -$15.3M – 178
2016
Q2 		$15.3M Buy
498,546
+775
+0.2% +$26.9K 0.5% 90
2016
Q1 		$18.6M Buy
497,771
+48,150
+11% +$1.81M 0.65% 65
2015
Q4 		$19.4M Sell
449,621
-4,590
-1% -$194K 0.69% 56
2015
Q3 		$17M Sell
454,211
-91,436
-17% -$3.25M 0.6% 72
2015
Q2 		$18.5M Sell
545,647
-1,535
-0.3% -$52.2K 0.55% 71
2015
Q1 		$19.4M Buy
547,182
+123,990
+29% +$4.44M 0.58% 69
2014
Q4 		$14.4M Buy
423,192
+15,669
+4% +$556K 0.43% 102
2014
Q3 		$15.7M Sell
407,523
-428
-0.1% -$16K 0.47% 80
2014
Q2 		$15.9M Buy
407,951
+395
+0.1% +$14.7K 0.49% 80
2014
Q1 		$13.9M Buy
407,556
+16,040
+4% +$497K 0.42% 93
2013
Q4 		$8.21M Sell
391,516
-77,019
-16% -$1.95M 0.28% 126
2013
Q3 		$11M Buy
468,535
+165,514
+55% +$4.7M 0.38% 112
2013
Q2 		$8.14M Buy
+303,021
New +$8.78M 0.49% 95

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Stephens Investment Management Group's MYGN Position: Q3 2016 in Review

Stephens Investment Management Group sold out of Myriad Genetics (MYGN) in Q3 2016, closing a stake of 498,546 shares — an estimated $15.3M sold.

Stephens Investment Management Group first reported a position in MYGN in Q2 2013 and held it in 13 quarters. The position peaked at $19.4M in Q4 2015. 223 funds tracked by Wall St. Rank hold MYGN as of Q3 2016.

  • Stephens Investment Management Group reported no remaining Myriad Genetics position as of Q3 2016 after selling out during the quarter.
  • Stephens Investment Management Group sold 498,546 Myriad Genetics shares in Q3 2016, an estimated $15.3M.
  • Stephens Investment Management Group first reported a position in Myriad Genetics in Q2 2013 and held it in 13 quarters.
  • Stephens Investment Management Group's Myriad Genetics position peaked at $19.4M in Q4 2015.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2016.

Based on Stephens Investment Management Group's 13F filing for Q3 2016, filed 10 Nov 2016.